Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Nichola Cooper

19PUBLICATIONS
81CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthHaematological tumoursPharmacogenomicsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

Sort by Publication Date:
|Jun 04, 2026
Exploring the Burden on Patients Living With and Receiving Treatment for Immune Thrombocytopenia (ITP): Patient and Physician Perceptions From the ITP World Impact Survey (I-WISh) 2.0.

|Apr 06, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 Trial.

Nichola Cooper, Catherine M Broome, Yoshitaka Miyakawa

|Aug 18, 2025
Patient survey in immune thrombocytopenia (ITP): Identifying unmet needs related to treatment and disease control in patients living in the United States.

Nichola Cooper, Caroline Kruse, Sharon Deneen Morgan

|May 06, 2025
Treatment Landscape in Pediatric Immune Thrombocytopenia: Addressing Unmet Needs.

Joana Azevedo, Jennifer DiRaimo, Cindy Neunert

|Jan 23, 2025
Efficacy and Safety Results With Rilzabrutinib, an Oral Bruton Tyrosine Kinase Inhibitor, in Patients With Immune Thrombocytopenia: Phase 2 Part B Study.

Nichola Cooper, A J Gerard Jansen, Robert Bird

|Nov 18, 2024
Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double-blind, placebo-controlled phase 3 studies and their open-label extension.

Nichola Cooper, James B Bussel, Maciej Kaźmierczak

Pageof 4

Frequent Collaborators

5 joint publications

James Bussel

3 joint publications

A J Gerard Jansen

3 joint publications

David J Kuter

3 joint publications

Terry Gernsheimer

3 joint publications

Drew Provan

2 joint publications

Milan Kostal

2 joint publications

Robert Bird

2 joint publications

Stuart Adams

2 joint publications

Vickie McDonald

2 joint publications

Jiri Mayer

Frequent Collaborators

5 joint publications

James Bussel

3 joint publications

A J Gerard Jansen

3 joint publications

David J Kuter

3 joint publications

Terry Gernsheimer